The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity

European Journal of Internal Medicine

Volumn 26, Issue 8, 2015, Pages 623-627

  Klimczak, Katarzyna ^a   Lykowska Szuber, Liliana ^a   Eder, Piotr ^a   Krela Kazmierczak, Iwona ^a   Stawczyk Eder, Kamila ^a   Szymczak, Aleksandra ^a   Michalak, Michal ^b   Studniarek, Adam ^a   Linke, Krzysztof ^a  

^a Ginekologiczno Po o niczy Szpital Kliniczny im Heliodora wi cickiego Uniwersytetu Medycznego im Karola Marcinkowskiego   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Colonoscopy; Crohn's disease; Fecal markers; Lactoferrin; Mucosal healing

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; FECAL LACTOFERRIN; INFLIXIMAB; LACTOFERRIN; MESALAZINE; PROBIOTIC AGENT; STEROID; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ASSESSMENT; COLON; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FECES ANALYSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; LARGE INTESTINE; MAGNETIC RESONANCE ENTEROGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REMISSION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SIMPLE ENDOSCOPIC SCORE FOR CROHN DISEASE; STEROID THERAPY; YOUDEN INDEX; ADOLESCENT; CHEMISTRY; INTESTINE MUCOSA; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; COLON; CROHN DISEASE; FECES; FEMALE; HUMANS; INTESTINAL MUCOSA; LACTOFERRIN; MALE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84943657483     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2015.06.015     Document Type: Article

References (32)

1. M. Lodyga, P. Eder, W. Bartnik, M. Gonciarz, M. Klopocka, K. Linke, and et al. Guidelines for the management of Crohn's disease. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology Przegl Gastroenterol 7 2012 317 338
2. R. D'Inca, and R. Caccaro Measuring disease activity in Crohn's disease: what is currently available to the clinician Clin Exp Gastroenterol 7 2014 151 161
3. J.A. Tibble, and I. Bjarnason Non-invasive investigation of inflammatory bowel disease World J Gastroenterol 7 4 2001 460 465
4. A.D. Dwarakanath, I.A. Finnie, C.M. Beesley, G.M. O'Dowd, J. Nash, H.H. Tsai, and et al. Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis Clin Sci (Lond) 92 3 1997 307 313
5. K.D. Fine, F. Ogunji, J. George, M.D. Niehause, and R.L. Guerrant Utility of a rapid fecal latex agglutination test detecting the neutrophil proein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea Am J Gastroenterol 93 8 1998 1300 1305
6. R. D'Incà, E. Dal Pont, V. Di Leo, A. Ferronato, W. Fries, M.G. Vettorato, and et al. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease Int J Colorectal Dis 22 4 2007 429 437
7. R. Sidhu, P. Wilson, A. Wright, C.W. Yau, F.A. D'Cruz, L. Foye, and et al. Faecal lactoferrin - a novel test to differentiate between the irritable and inflamed bowel? Aliment Pharmacol Ther 31 12 2010 1365 1370
8. X.L. Zhou, W. Xu, X.X. Tang, L.S. Luo, J.F. Tu, C.J. Zhang, and et al. Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis BMC Gastroenterol 14 2014 121
9. R. Caccaro, R. D'Incà, M. Martinato, E.D. Pont, S. Pathak, A.C. Frigo, and et al. Fecal lactoferrin and intestinal permeability are effective non-invasive markers in the diagnostic work-up of chronic diarrhea Biometals 27 5 2014 1069 1076
10. J.P. Gisbert, and A.G. McNicholl Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease Dig Liver Dis 41 1 2009 56 66
11. R.B. Canani, G. Terrin, L. Rapacciuolo, E. Miele, M.C. Siani, C. Puzone, and et al. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease Dig Liver Dis 40 7 2008 547 553
12. U. Kopylov, G. Rosenfeld, B. Bressler, and E. Seidman Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease Inflamm Bowel Dis 20 4 2014 742 756
13. T. Sipponen Diagnostics and prognostics of inflammatory bowel disease with fecal neutrophil-derived biomarkers calprotectin and lactoferrin Dig Dis 31 3-4 2013 336 344
14. E.K. Wright, P. De Cruz, R. Gearry, A.S. Day, and M.A. Kamm Fecal biomarkers in the diagnosis and monitoring of Crohn's disease Inflamm Bowel Dis 20 9 2014 1668 1677
15. T. Yamamoto, M. Shiraki, T. Bamba, S. Umegae, and K. Matsumoto Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy Int J Colorectal Dis 29 4 2014 485 491
16. T. Sipponen, P. Kärkkäinen, E. Savilahti, K.L. Kolho, H. Nuutinen, U. Turunen, and et al. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings Aliment Pharmacol Ther 28 10 2008 1221 1229
17. T. Sipponen, C.G. Björkesten, M. Färkkilä, H. Nuutinen, E. Savilahti, and K.L. Kohlo Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment Scand J Gastroenterol 45 3 2010 325 331
18. T. Sipponen, E. Savilahti, K.L. Kolho, H. Nuutinen, U. Turunen, and M. Farkkila Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings Inflamm Bowel Dis 14 1 2008 40 46
19. J.P. Gisbert, F. Bermejo, J.L. Pérez-Calle, C. Taxonera, I. Vera, A.G. McNicholl, and et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse Inflamm Bowel Dis 15 8 2009 1190 1198
20. E.K. Wright, M.A. Kamm, P. De Cruz, A.L. Hamilton, K.J. Ritchie, E.O. Krejany, and et al. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery Gastroenterology Jan 22 2015 10.1053/j.gastro.2015.01.026 [pii: S0016-5085(15)00111-0 [Epub ahead of print]]
21. R. Sidhu, D.S. Sanders, P. Wilson, L. Foye, S. Morley, and M.E. McAlindon Faecal lactoferrin, capsule endoscopy and Crohn's disease. Is there a three way relationship? A pilot study J Gastrointestin Liver Dis 19 3 2010 257 260
22. J.P. Gisbert, A.G. McNicholl, and F. Gomollon Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease Inflamm Bowel Dis 15 11 2009 1746 1754
23. S. Farnaud, and R.W. Evans Lactoferrin - a multifunctional protein with antimicrobial properties Mol Immunol 40 7 2003 395 405
24. J. Lis, M. Orczyk-Pawiłowicz, and I. Kątnik-Prastowska Proteins of human milk involved in immunological processes Postepy Hig Med Dosw 67 2013 529 547
25. M. Daperno, G. D'Haens, G. van Assche, F. Baert, P. Bulois, and V. Maunoury Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD Gastrointest Endosc 60 2004 505 512
26. P. Eder, K. Katulska, L. Lykowska-Szuber, K. Stawczyk-Eder, I. Krela-Kaźmierczak, K. Linke, and et al. Simple Enterographic Activity Score for Crohn's Disease: comparison with endoscopic, biochemical, and clinical findings Pol Arch Med Wewn 123 7-8 2013 378 385
27. S. Vermeire, G. Van Assche, and P. Rutgeerts Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55 3 2006 426 431
28. L. Peyrin-Biroulet, W. Reinisch, J.F. Colombel, G.J. Mantzaris, A. Kornbluth, and R. Diamond Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial Gut 63 1 2014 88 95
29. J. Weh, C. Antoni, C. Weiß, P. Findeisen, M. Ebert, U. Böcker, and et al. Discriminatory potential of C-reactive protein, cytokines, and fecal markers in infectious gastroenteritis in adults Diagn Microbiol Infect Dis 77 1 2013 79 84
30. S.V. Kane, W.J. Sandborn, P.A. Rufo, A. Zholudex, J. Boone, D. Lyerly, and et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation Am J Gastroenterol 98 6 2003 1309 1314
31. M. Scarpa, R. D'Incà, D. Basso, C. Ruffolo, L. Polese, E. Bertin, and et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease Dis Colon Rectum 50 6 2007 861 869
32. M. Calafat, E. Cabré, M. Mañosa, T. Lobaton, L. Marin, and E. Domenech High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling? Inflamm Bowel Dis 21 5 2015 1072 1076